CDK7 inhibition suppresses aberrant hedgehog pathway and overcomes resistance to smoothened antagonists

The aberrant hedgehog (Hh) pathway plays important roles in multiple cancer types, therefore serving as a promising drug target. Current clinically available hedgehog-targeted drugs act mostly by antagonizing the upstream component smoothened; however, both primary and acquired resistance to FDA-app...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Proc Natl Acad Sci U S A
Asıl Yazarlar: Liu, Fang, Jiang, Wenyan, Sui, Yi, Meng, Wei, Hou, Linjun, Li, Tiantian, Li, Meng, Zhang, Lei, Mo, Jialin, Wang, Jiajia, Zhao, Yang, Zhang, Liye, Ma, Jie, Tang, Yujie
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: National Academy of Sciences 2019
Konular:
PNAS Plus
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6600918/
https://ncbi.nlm.nih.gov/pubmed/31182587
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1815780116
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller